Results 191 to 200 of about 8,893 (235)

Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies. [PDF]

Diabetes Obes Metab
Thomsen RW, Mailhac A, Løhde JB, Pottegård A.   +3 more
europepmc   +1 more source

Adverse Liver and Renal Outcomes After Initiating SGLT-2i and GLP-1RA Therapy Among Patients With Diabetes and MASLD. [PDF]

J Diabetes
Krishnan A, Schneider CV, Mukherjee D, Woreta TA, Alqahtani SA.   +4 more
europepmc   +1 more source

GLP-1RA may open a new era for MASLD treatment

Clinical and Molecular Hepatology
Ye Feng, Chengfu Xu
openaire   +1 more source

An overview of randomized clinical trials of fixed-ratio combinations of basal insulin plus GLP-1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes. [PDF]

Diabetes Obes Metab
Bolli GB, Porcellati F, Lucidi P, Fanelli CG, Perseghin G, Horowitz M, Owens DR.   +6 more
europepmc   +1 more source

GIP/GLP-1RA as adjunctive to automated insulin delivery in adults with Type 1 diabetes (the AID-JUNCT trial): Study protocol for a prospective, randomized, clinical trial. [PDF]

PLoS One
Fragozo-Ramos MC, Schenker G, Hepprich M, Gallo-Villegas J, Züger T, Garcia-Tirado J.   +5 more
europepmc   +1 more source

The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required. [PDF]

Metabolites
Sinclair AJ, Abdelhafiz AH.
europepmc   +1 more source

Can the incidence of voluntarily reported side effects support the argument for a clinically relevant GLP-1RA tachyphylaxis? Comment on Br J Anaesth 2025; 134:1486-1496. [PDF]

Br J Anaesth
Hobai IA.
europepmc   +1 more source

The Effectiveness of an Electronic Decision Support Algorithm to Optimize Recommendations of SGLT2i and GLP-1RA in Patients with Type 2 Diabetes upon Discharge from Internal Medicine Wards. [PDF]

J Clin Med
Ayalon-Dangur I, Jaffe E, Grossman A, Hendel H, Oved Y, Shaked A, Shimon I, Basharim B, Abo Molhem M, McNeil R, Abuhasira R, Shitrit T, Azulay Gitter L, El Saleh R, Shochat T, Eliakim-Raz N.   +15 more
europepmc   +1 more source

Impact of GLP-1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol-Associated Liver Disease and Type 2 Diabetes. [PDF]

Liver Int
Rashid Z, Woldesenbet S, Khalil M, Iyer S, Khan MMM, Altaf A, Munir MM, Catalano G, Mumtaz K, Pawlik TM.   +9 more
europepmc   +1 more source